These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

703 related articles for article (PubMed ID: 27831759)

  • 1. Triple Therapy of HER2
    Zolata H; Afarideh H; Davani FA
    Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization and theranostic evaluation of Indium-111 labeled multifunctional superparamagnetic iron oxide nanoparticles.
    Zolata H; Abbasi Davani F; Afarideh H
    Nucl Med Biol; 2015 Feb; 42(2):164-70. PubMed ID: 25311750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
    Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
    Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy.
    Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY
    Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immuno-hyperthermia effected by antibody-conjugated nanoparticles selectively targets and eradicates individual cancer cells.
    Kagawa T; Matsumi Y; Aono H; Ohara T; Tazawa H; Shigeyasu K; Yano S; Takeda S; Komatsu Y; Hoffman RM; Fujiwara T; Kishimoto H
    Cell Cycle; 2021 Jul; 20(13):1221-1230. PubMed ID: 34148497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted antitumor efficacy and imaging via multifunctional nano-carrier conjugated with anti-HER2 trastuzumab.
    Choi WI; Lee JH; Kim JY; Heo SU; Jeong YY; Kim YH; Tae G
    Nanomedicine; 2015 Feb; 11(2):359-68. PubMed ID: 25262581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Razumienko EJ; Chen JC; Cai Z; Chan C; Reilly RM
    J Nucl Med; 2016 Mar; 57(3):444-52. PubMed ID: 26429962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex of TNF-α and Modified Fe
    Teo P; Wang X; Chen B; Zhang H; Yang X; Huang Y; Tang J
    Cancer Biother Radiopharm; 2017 Dec; 32(10):379-386. PubMed ID: 29265918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functionalized polymersomes with outlayered polyelectrolyte gels for potential tumor-targeted delivery of multimodal therapies and MR imaging.
    Chiang WH; Huang WC; Chang CW; Shen MY; Shih ZF; Huang YF; Lin SC; Chiu HC
    J Control Release; 2013 Jun; 168(3):280-8. PubMed ID: 23562635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with
    Cędrowska E; Pruszyński M; Gawęda W; Żuk M; Krysiński P; Bruchertseifer F; Morgenstern A; Karageorgou MA; Bouziotis P; Bilewicz A
    Molecules; 2020 Feb; 25(5):. PubMed ID: 32106568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic hyperthermia and pH-responsive effective drug delivery to the sub-cellular level of human breast cancer cells by modified CoFe
    Oh Y; Moorthy MS; Manivasagan P; Bharathiraja S; Oh J
    Biochimie; 2017 Feb; 133():7-19. PubMed ID: 27916642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LyP-1-conjugated Fe
    Teo P; Wang X; Zhang J; Zhang H; Yang X; Huang Y; Tang J
    J Biomater Sci Polym Ed; 2018 Feb; 29(2):181-194. PubMed ID: 29165044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
    Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
    Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermoresponsive core-shell magnetic nanoparticles for combined modalities of cancer therapy.
    Purushotham S; Chang PE; Rumpel H; Kee IH; Ng RT; Chow PK; Tan CK; Ramanujan RV
    Nanotechnology; 2009 Jul; 20(30):305101. PubMed ID: 19581698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation and evaluation of APTES-PEG coated iron oxide nanoparticles conjugated to rhenium-188 labeled rituximab.
    Azadbakht B; Afarideh H; Ghannadi-Maragheh M; Bahrami-Samani A; Asgari M
    Nucl Med Biol; 2017 May; 48():26-30. PubMed ID: 28189044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preclinical application of MR and fluorescent dual-modality imaging combined with photothermal therapy in HER-2 positive breast cancer].
    Luo XJ; Li J; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):587-593. PubMed ID: 30139028
    [No Abstract]   [Full Text] [Related]  

  • 18. Functionalized nanoscale β-1,3-glucan to improve Her2+ breast cancer therapy: In vitro and in vivo study.
    Nasrollahi Z; Mohammadi SR; Mollarazi E; Yadegari MH; Hassan ZM; Talaei F; Dinarvand R; Akbari H; Atyabi F
    J Control Release; 2015 Mar; 202():49-56. PubMed ID: 25597638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting.
    Mojica Pisciotti ML; Lima E; Vasquez Mansilla M; Tognoli VE; Troiani HE; Pasa AA; Creczynski-Pasa TB; Silva AH; Gurman P; Colombo L; Goya GF; Lamagna A; Zysler RD
    J Biomed Mater Res B Appl Biomater; 2014 May; 102(4):860-8. PubMed ID: 24458920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetite nanoparticle-loaded anti-HER2 immunoliposomes for combination of antibody therapy with hyperthermia.
    Ito A; Kuga Y; Honda H; Kikkawa H; Horiuchi A; Watanabe Y; Kobayashi T
    Cancer Lett; 2004 Aug; 212(2):167-75. PubMed ID: 15279897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.